Medical Therapy for Heart Failure With Reduced Ejection FractionStephen J. Greene, Gregg C. Fonarow, Laine Thomas et al.|Journal of the American College of Cardiology|2018Cited by 1.3k
Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionStephen J. Greene, Javed Butler, Gregg C. Fonarow et al.|Journal of the American College of Cardiology|2019Cited by 484
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection FractionStephen J. Greene, Gregg C. Fonarow, Javed Butler et al.|JAMA Cardiology|2021Cited by 153
Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular careJedrek Wosik, Neha J. Pagidipati, Megan E. B. Clowse et al.|American Heart Journal|2020Cited by 103
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort studyPushpa Narayanaswami, Gilles Hoffmann, Donald B. Sanders et al.|The Lancet Neurology|2024Cited by 53